Turn Therapeutics (TTRX) Total Liabilities (2024 - 2026)

Turn Therapeutics' Total Liabilities history runs 3 years deep, the most recent figure standing at $12.5 million for Q1 2026.

• In Q1 2026, Total Liabilities changed N/A year-over-year to $12.5 million; the TTM figure through Mar 2026 stood at $12.5 million (changed N/A YoY), while the FY2025 annual figure was $7.5 million, up 235.78% from the prior year.
• Total Liabilities for Q1 2026 stood at $12.5 million, up from $7.5 million in the prior quarter.
• The five-year high for Total Liabilities was $12.5 million in Q1 2026, with the low at $2.2 million in Q4 2024.
• The 3-year median for Total Liabilities is $5.6 million (2025), against an average of $6.5 million.
• Peak annual rise in Total Liabilities reached 235.78% in 2025, while the deepest fall reached 235.78% in 2025.
• Turn Therapeutics' Total Liabilities stood at $2.2 million in 2024, then surged by 235.78% to $7.5 million in 2025, then surged by 67.57% to $12.5 million in 2026.
• Business Quant data shows TTRX's Total Liabilities at $12.5 million in Q1 2026, $7.5 million in Q4 2025, and $3.8 million in Q3 2025.